Doctor Herbert Himmel

Bayer AG, Wuppertal (Germany)

Follow

Contributor content

Lack of pro-arrhythmic potential for the novel soluble guanylate cyclase stimulator vericiguat: results from preclinical studies

Presentation

Lack of pro-arrhythmic potential for the novel soluble guanylate cyclase stimulator vericiguat: results from preclinical studies

ESC 365 is supported by

novartis

Explore sponsored resources